IL2 and neoplasm: Similar context-dependent behavior of CD25-biased IL-2 agonists was described in a recent study,22 which reported that Tregs within the tumor microenvironment are present at high baseline frequencies, and many exist in an activated, proliferative state due to local IL-2 and other biochemical cues.